The increasing number of multidrug-resistant Mycobacterium tuberculosis strains has stimulated the interest of investigators in finding a rapid method for susceptibility testing. We used commercially available rRNA DNA-bioluminescence-labelled probes (Accu-Probe, Gen Probe, Inc. San Diego, Calif.) for this purpose. The study was performed in three chronological steps. (i) We studied the correlation between the photometric light units (PLUs) given by the hybridization method, the numbers of CFU per milliliter, and turbidity as nephelometric units for six different inocula of an M. tuberculosis strain over 14 days. A good correlation (c > 0.9; P < 0.05) was found from the third day for all concentrations used. (ii) Over a period of 14 days we studied the evolution of the PLUs for 20 strains growing in medium with 0.2 l of isoniazid (H) per ml and 18 strains in medium with 1 l of rifampin (R) per ml to standardize the method. Susceptible and resistant strains were used according to the reference proportions method in Middlebrook 7H10, and the MICs were determined in solid and liquid media. The final inoculum of a 10 ؊2 dilution from a McFarland no. 1 standard and reading at 3 and 5 days provided the best results. A quotient was established to find a cutoff point between resistant and susceptible strains. (iii) We used the standardized parameters in 117 tests with H and R. On day 3, the sensitivity, specificity, positive predictive value, and negative predictive value for detecting resistant strains were 86.8, 100, 100, and 90.1%, respectively, and on day 5 they were 96.2, 100, 100, and 94%, respectively. We concluded that the method is readily available, is easy to perform, and could be useful for screening resistant M. tuberculosis strains.
Multidrug-resistant Mycobacterium tuberculosis strains are increasing in number, making it important to identify patients infected with resistant strains. There is a great need for rapid methods for determining resistance to isoniazid (H) or rifampin (R), the two most important drugs in the treatment of tuberculosis. In some cases we must wait 3 or more weeks to obtain a positive culture for diagnosis and a further 3 weeks for the susceptibility test result when solid media are used with conventional techniques, or we must wait 1 week to 12 days when radiometric methods with the BACTEC system are used (16, 18, 19, 21) .
Other rapid methods have been developed to establish the susceptibility of M. tuberculosis to H and R. Bercovier et al. (1) developed a method for determining the susceptibilities of M. tuberculosis and M. bovis BCG to R by using rhodamine 123 and fluorescein diacetate to measure bacterial membrane potential after 24 h of incubation. Nilson et al. (15) described a susceptibility assay with bioluminescence for the detection of mycobacterial ATP, with the results being available within 5 to 7 days of incubation. Jacobs et al. (10) and Cooksey et al. (5) , using genetic engineering, developed a rapid method for screening the efficacies of antimicrobial agents by inserting the firefly luciferase gene into the genetic material of a virus specific for M. tuberculosis. Telenti et al. (22) detected all Rresistant mutants by means of a rapid molecular biology-based method, PCR-single-strand conformation polymorphism analysis, which allowed for the rapid detection of single-base changes in PCR products without sequencing of the rpoB gene.
We follow the line of work proposed in 1989 by Kawa et al. (11) , who used DNA probes for hybridization with RNA of the M. tuberculosis complex; the DNA probe susceptibility test could be completed in 3 to 5 days.
(This work was presented in part at the 16th Annual Meeting of the European Society for Mycobacteriology, Pisa, Italy, 4 to 7 June 1995 [abstract OP28].)
MATERIALS AND METHODS
Our study was carried out as follows. (i) In order to measure the bacterial growth, we correlated the increase in the amount of rRNA of M. tuberculosis strains with two different parameters: the numbers of CFU per milliliter and turbidity. (ii) We studied the increase in the amount of rRNA of M. tuberculosis in medium with H and R in comparison with the increase in the amount of rRNA in medium without drugs in order to develop a rapid method for detecting resistant strains of M. tuberculosis. (iii) We used the method in 117 tests with strains resistant to H or R.
Study of mycobacterial growth: correlation of photometric light units (PLUs), with numbers of CFU per milliliter and nephelometric units (NUs). (i) Strain, medium, and culture conditions. M. tuberculosis H37Rv (ATCC 27294) was used as a reference strain. The medium used was Middlebrook 7H9 broth base (Difco Laboratories, Detroit, Mich.) supplemented with 10% oleic acid, albumin, dextrose, and catalase enrichment (OADC; Difco). Cultures were prepared from a dilution with a turbidity equal to that of a McFarland no. 1 standard (approximately 10 7 CFU/ml) and were then diluted at progressive 10-fold dilutions to 10 Ϫ5 (10 2 to 10 6 CFU of the initial concentration per ml) in tubes with glass beads containing 9 ml of medium. All tubes were incubated statically at 37°C.
(ii) Growth determination. From the day of inoculation (day 0) until day 14, serial 10-fold dilutions of all the broth culture tubes were sampled daily and the samples were used for various tests. (i) The samples were plated on Middlebrook 7H10 agar plates (Difco) to determine the numbers of CFU per milliliter. Viable counts were carried out in duplicate. Plates were incubated at 37°C in the presence of 5% CO 2 for 3 weeks. (ii) They were used to perform the hybridization method by the commercially available AccuProbe M. tuberculosis complex test (Gen Probe, Inc., San Diego, Calif.) (6, 8, 13) according to the instructions of the manufacturer. The test consists of the following four basic steps: sample preparation, hybridization, selective chemical degradation, and chemiluminescence. The amount of light emitted from the acridinium was measured in PLUs with a luminometer (AccuLDR, PAL; Gen Probe, Inc.). (iii) Finally, the turbidities of the samples were determined in a Dinko-15 turbidimeter (Dinter S.A., Barcelona, Spain). The correlation between PLUs, samples were the numbers of CFU per milliliter, and NUs was calculated by using the Spearman correlation coefficient.
Study of the mycobacterial rRNA increase in medium with antibiotics, reference methods, and standardization of the method. (i) Medium. Middlebrook 7H9 broth plus OADC (10%) was dispensed into tubes (9 ml in each tube).
(ii) Strains. To study the mycobacterial rRNA increase, 9 H-resistant and 11 H-susceptible strains and 10 R-susceptible and 8 R-resistant strains were used.
(iii) Antibiotic concentration. Stock drug solutions of H and R (Sigma Chemical Co., St. Louis, Mo.) were prepared at 10,000 g/ml in appropriate solvents (distilled water for H and ethylene alcohol for R). They were stored at Ϫ20°C in 1-ml aliquots until they were used. In compliance with previous recommendations (9, 12) , working solutions of the drugs were prepared in distilled water to obtain a final concentration of 0.2 g/ml for H and 1.0 g/ml for R.
(iv) Inoculum. The turbidity of each culture was adjusted to that of a McFarland no. 1 standard and each culture was diluted 10-fold. Then, 1 ml of each culture was added to a control tube and to the tubes with H and R to final dilutions of 10 Ϫ2 . All tubes were incubated at 37°C until day 9. On days 0, 1, 3, 4, 5, 7, and 9 they were vortexed and samples were taken to measure PLUs, the numbers of CFU per milliliter, and NUs.
(v) Hybridization. The hybridization test was performed from the control tube on the day of the inoculation (day 0) to establish the background PLUs (C 0 ). The PLUs on the various days of incubation (days x) were determined for the control tube (C x ) and the tubes with antibiotics (P x ). The quotient (P x Ϫ C 0 )/(C x Ϫ C 0 ) was used daily to relate the background on day 0 to the PLUs in the control tube and in the tube with antibiotic.
(vi) Statistical analysis. Assuming a prior probability of 0.5 for each of the two groups (susceptible and resistant) from the values of the quotient, the discriminant function was used to obtain a cutoff value and then calculate the percentage of strains correctly classified.
(vii) Reference methods. Susceptibility and resistance were determined by two conventional methods: the proportion method in Middlebrook 7H11 agar plates (9) and MIC determination on 7H11 medium plus OADC and 7H9 broth base plus OADC (20, 23) . Those strains presenting Ͻ1% resistant bacilli by the proportions method and for which the MIC was equal to or less than 0.125 g/ml for H or 0.5 g/ml for R were classified as susceptible. For this step we used susceptible or resistant strains in accordance with all reference methods.
Application of the standardized method. (i) Medium and antibiotic concentration.
From the results obtained in the steps described above, for the hybridization susceptibility test (HST) of each strain we used three tubes with Middlebrook 7H9 broth base plus 10% OADC. The first tube was used as a control (without antibiotics), a final concentration of 0.2 g of H per ml was added to the second tube, and a final concentration of 1 g of R per ml was added to the third tube.
(ii) Inoculum. We used the same inoculum used in the preceding step (final concentration of 10 Ϫ2 for a culture with a turbidity equivalent to that of a McFarland no. 1 standard).
(iii) Hybridization tests. The control tube was tested to determine the background PLUs on day 0. On day 3 after incubation, the test was done with all tubes. Strains with quotient values below 0 were considered susceptible, and those with quotient values above 0.2 were considered resistant. Strains with intermediate values (between 0 and 0.2) were incubated, and the test was repeated on day 5.
(iv) Strains used. For application of the standardized method, a total of 117 tests were performed with 59 M. tuberculosis strains with various levels of resistance to H and R. We chose strains with different percentages of resistance by the proportions method, as follows: for H, 59 strains (28 susceptible strains, 5 strains with levels of resistance of between 1 and 25%, 7 strains with levels of resistance of between 26 and 50%, and 19 strains with levels of resistance of Ͼ50%); for R, 58 strains (37 susceptible strains, 4 strains with levels of resistance of between 1 and 25%, 7 strains with levels of resistance of between 26 and 50%, and 10 strains with levels of resistance of Ͼ50%).
(v) Statistical analysis. The sensitivity, specificity, positive predictive value, and negative predictive value of the method were established for days 3 and 5 by means of discriminant analysis. To study the relation between the results by two methods (hybridization and proportions), we used the Pearson 2 test and the McNemar test (17) .
RESULTS
Mycobacterial growth: correlation of hybridization, viability, and turbidity. The correlation between PLUs, the numbers of CFU per milliliter, and NUs detected daily is presented in Table 1 . On day 3 all parameters had good and significant statistical correlations. The correlation of the same parameters for the various dilutions is presented in Table 2 . The best results corresponded to a dilution of 10 Ϫ2 , and the dilution represents approximately 10 5 CFU/ml. The latency period before exponential growth depended on the initial dilution. On day 0 the PLUs for tubes with turbidities equivalent to that of a McFarland no. 1 standard and for dilutions of 10 Ϫ1 to 10 Ϫ5 were 6,552, 606, 118, 56, 60, and 37, respectively, and the latency periods before exponential growth from the 10 Ϫ2 to 10 Ϫ5 dilutions were 3, 6, 9, and 13 days, respectively, so that the shortest period of latency before exponential growth corresponded to the 10 Ϫ2 dilution. Table 3 indicates the values of the three parameters studied with this dilution in the first week of incubation.
Mycobacterial rRNA increase in medium with antibiotics: standardization of the method. Table 4 indicates the increase in mean PLUs for all strains from day 0 to day 9 in the control tubes and in the tubes with H for susceptible and resistant strains.
From day 2 there was a statistical difference between control tubes and tubes with antibiotic for susceptible strains. There was no difference between control tubes and tubes with antibiotic for resistant strains.
Finally, there was a significant difference between susceptible and resistant strains from day 3. Similar values were obtained when R was tested ( Table 5) . As in the first step, the correlation between the numbers of CFU per milliliter PLUs, and NUs was also studied. The control tubes for the 20 strains used showed correlation values of between 0.790 and 0.905, and P was Ͻ0.0001 for the three parameters studied. In the tubes with drugs (Table 6 ), PLUs and the numbers of CFU per milliliter correlated in all cases, but in the case of the susceptible strains, no correlation was found between NUs and PLUs or between NUs and the numbers of CFU per milliliter.
The mean values of the quotient established are presented in Table 7 for strains resistant and susceptible to the two drugs. In all cases susceptible strains had a quotient value below 0. With the discriminant function, the cutoff point between susceptible and resistant strains on day 2 was 0.2 for H and 0.3 for R. On all days of the study, resistant strains had a quotient value above 0.2 for both drugs.
Application of the standardized method. Table 8 indicates the sensitivity, specificity, positive predictive value, and negative predictive value on day 3 and on day 5 of the hybridization method for the 117 tests that were performed.
For H, 55 of the 59 strains tested were correctly classified on day 3. Four strains had quotient values of between 0 and 0.2 (0.048, 0.023, 0.147, and 0.195, respectively). On day 5 the same four strains had quotient values of 0.087, Ϫ0.013, 0.500, and 0.531 respectively. According to the established method, the strain with a value of 0.087 remained unclassified. This strain and the strain with a quotient value of Ϫ0.013 were resistant by the proportion method, but the H MIC for the strains was 0.250 g/ml. No relation was found between HST results and the percentage of resistance by the proportion method.
When susceptibility to R was evaluated on day 3, three strains had intermediate quotient values (between 0 and 0.2) of 0.194, 0.182, and 0.106, respectively. On day 5 the same strains had quotient values of 0.613, 0.357, and 0.878, respectively; therefore, they were correctly classified as resistant.
According to the established cutoff point and in reference to the proportion method, HST correctly classified 94.8% of the strains on day 3 and 98.3% of the strains on day 5. 
DISCUSSION
Multidrug-resistant M. tuberculosis strains are a serious problem in groups with a high risk of coinfection with M. tuberculosis and human immunodeficiency virus (HIV). In 1994, the incidence of tuberculosis in Barcelona, Spain, was 58.5/100,000 inhabitants (4) and the incidence of HIV infection was 29.5/100,000 inhabitants (7), 50.8% of whom were intravenous drug users. These groups can easily be infected with M. tuberculosis, but their compliance with the treatment for tuberculosis is poor. In Spain an outbreak of multidrug-resistant strains was recently described in a ward for HIV-infected patients (3). In these situations, rapid methods are needed to reduce the time required to detect M. tuberculosis and its susceptibility to antituberculosis drugs, and efforts in this direction by clinical laboratories have been reported in the United States (2) .
Two methods for the rapid detection of drug-resistant M. tuberculosis strains are commercially available: the radiometric system (RS; Becton Dickinson) and the detection of R-resistant genes (InnoLipa Rif TB; Innogenetics, Zwijndrecht, Belgium). Good results have been obtained with genetic resistance probes, their advantage being that they can be used directly with clinical specimens, but they do not detect all resistant strains and they can be used only by laboratories with the technical capacity to handle genetic methods. Thus, methods based on mycobacterial growth, such as RS, are slower but more useful in clinical laboratories.
In the present study we have demonstrated that the detection of rRNA is a good and early index of the metabolic activity of the microorganisms because of the correlation between the PLUs measured by commercially available hybridization probes (recommended for use in the identification of M. tuberculosis complex) and the numbers of CFU per milliliter. Recently, Miyamoto et al. (14) , using culture media similar to those used in the present study obtained the same conclusion. Of the three parameters evaluated as indices of mycobacterial growth, turbidity has no significant correlation with the other two parameters, probably due to the peculiar growth of M. tuberculosis, which does not enable a homogeneous suspension to be obtained. On the basis of the conclusion presented above, we have developed a new, rapid way of detecting resistance in M. tuberculosis strains which depends on mycobacterial growth. It can be used for testing the susceptibilities of mycobacterial strains to several antibiotics and gives clear values for PLU quotients between susceptible and resistant strains. Of the 117 tests done with H and R, on day 3 of incubation we obtained a result in accordance with that of the reference method for 110 tests, that is, 94.8% concordance. Although all susceptible strains had a quotient value below 0 (Table 7 ) and the cutoff point obtained by statistical methods was 0.2, we decided to repeat the tests on day 5 with an intermediate quotient value of between 0 and 0.2 because some resistant M. tuberculosis strains showed very slow growth on solid media. In our study, tests with seven strains tested with H and three tested with R) gave these intermediate values. On day 5, when we retested the seven strains, five strains (two tested with H and all three tested with R) were correctly classified according to the reference methods (98.3% concordance); of the other two strains, one was classified as susceptible and the other remained intermediate by HST. Both strains were resistant to H by the proportion method and were moderately susceptible according to the MICs for the strains in liquid medium. These differences between susceptibility methods had been described in other reports (18) .
In comparison with RS, the method described here has the advantage that it does not use radiolabeled compounds; Kawa et al. (11) performed their work with 125 I-labeled probes because at that time no hybridization methods without radiolabeled compounds were available on the market. With RS, the time required to obtain susceptibility results is from 5 to 12 days after a growth index of 300 is reached, whereas by HST the time needed to obtain the results is 3 to 5 days, and a prolongation of the incubation time is not useful. Although the method described here starts with solid medium, further experience indicated that RS could be used as the primary culture and HST would be performed when the growth index is between 200 and 300 (unpublished data). A combination of the two methods, culture with RS and then HST, would probably be the quickest system for detecting resistant M. tuberculosis strains by methods that depend on mycobacterial growth.
Another nontechnical but important point is the price. It seems that the time taken to perform the test and the cost incurred are, in general, inversely proportional. For this work we have used a commercially available system for identification with the purpose of using it for susceptibility tests. We think that for the present it is very difficult to compare our method with other rapid methods in this respect, particularly when prices are different in different countries. By this method, the price for testing two drugs is the same as the price of four tests for identification performed by the AccuProbe M. tuberculosis complex test.
We conclude that the method described here is reliable for testing the susceptibility or resistance of M. tuberculosis strains when compared with standardized methods, is easy to perform, can detect different mechanisms of resistance, and can be used in clinical laboratories.
